Abstract
Background: Controversial research has indicated potential neuroprotective qualities of lithium in the prevention of dementia, but it did not lead to a definite conclusion. Aim: We seek to examine whether lithium has a protective effect in an elderly population suffering from bipolar disorder. Patients and Methods: Of a retrospective cohort including 433 patient files that met inclusion criteria (age over 65 years and bipolar disease coded by ICD), 147 files contained enough relevant data. The patients’ files were divided into lithium users (LU) for those who used lithium for at least a minimum of 3 months and non-users (LNU) for those who did not use lithium at all or used it for a period of less than 3 months. We searched for dementia incidence in these two groups. Results: 433 files were collected initially through a computerized search using ICD10 code for bipolar affective disorder. One hundred twenty three files were excluded due to age (younger than 65 years), 7 were excluded due to neurological background, and 49 were excluded due to either a secondary or a not strictly bipolar psychiatric diagnosis. One hundred and seven were excluded due to insufficient/uncertain data. The remainders of 147 files were included in the final analysis. Twenty five of the 147 bipolar patients were diagnosed with dementia (17%). Amongst the 92 LNU patients, 16 developed dementia (17.4%) and of the 55 LU patients, 9 developed dementia (16.4%); Pearson’s χ2(1) = 0.026, p < 0.05. Our analysis showed no significant difference between the two groups. Conclusions: No cognitive protective qualities of lithium treatment in elderly bipolar patients were demonstrated by our study.
Highlights
Lithium compounds, mainly lithium salts are considered a “veteran” drug is psychiatry since 1948, when they were first shown by J
The remainders of 147 files were included in the final analysis
The goal of this research was to discern whether lithium has protective effects on the development of dementia in a narrowly defined group of patients, namely—elderly patients with a strictly bipolar diagnosis treated with lithium for a period of at least 3 months
Summary
Mainly lithium salts are considered a “veteran” drug is psychiatry since 1948, when they were first shown by J. Since lithium has been used mostly as a mood stabilizer for affective disorders, mainly bipolar disorder. It has been proved effective in preventing recurrent manic episodes in two meta analyses from 2004 and 2007, though inconclusive about its efficacy in preventing recurring depressive episodes [1] [2]. In AD mouse models and cell culture research, GSK-3 has been shown to phosphorylate the tau proteins, and having a role in creating the Aβ amyloid. Patients and Methods: Of a retrospective cohort including 433 patient files that met inclusion criteria (age over 65 years and bipolar disease coded by ICD), 147 files contained enough relevant data. Conclusions: No cognitive protective qualities of lithium treatment in elderly bipolar patients were demonstrated by our study
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
